TNFRSF4 and tuberculosis: It has been recently recognised that enhancing OX40 signaling leads to enhanced protection against TB, where delivery of an OX40 agonist in conjunction with the BCG vaccine provided superior immunity against M. tuberculosis infection in mice44.